Opinion Review
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Artif Intell Gastrointest Endosc. Aug 28, 2021; 2(4): 103-109
Published online Aug 28, 2021. doi: 10.37126/aige.v2.i4.103
Robotic pancreaticoduodenectomy: Where do we stand?
Hussein H Khachfe, Joseph R Habib, Mohamad A Chahrour, Ibrahim Nassour
Hussein H Khachfe, Ibrahim Nassour, Surgery Department, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, United States
Joseph R Habib, Surgery Department, Johns Hopkins University, Balitmore, MD 21287, United States
Mohamad A Chahrour, Surgery Department, Henry Ford Health System, Detroit, MI 48202, United States
Author contributions: Khachfe HH conceived the idea for the manuscript; Khachfe HH, Habib JR, Chahrour MA, and Nassour I reviewed the literature and drafted the manuscript; Nassour I critically reviewed the manuscript.
Conflict-of-interest statement: The authors report no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hussein H Khachfe, MD, Doctor, Research Fellow, Surgery Department, University of Pittsburgh Medical Center, 3550 Terrace St, Pittsburgh, PA 15261, United States. khachfehh@upmc.edu
Received: May 18, 2021
Peer-review started: May 18, 2021
First decision: June 22, 2021
Revised: June 24, 2021
Accepted: August 19, 2021
Article in press: August 19, 2021
Published online: August 28, 2021
Core Tip

Core Tip: The robotic Whipple procedure is a safe and technically feasible surgical operation. Robotic pancreaticoduodenectomy has shown favorable outcomes and is currently increasing in widespread implementation. Prospective trials are needed before this relatively new approach can be fully adopted as a standard of care in patients with pancreatic neoplasms.